7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 
      
    		   
      cash flows provided by/ (used in), operating activities
    		   
      income before tax
    		-59,788 -146,812 -62,495 
      adjustments for:
    		   
      finance income
    		-13,870 -17,302 -18,420 
      finance costs
    		5,475 5,820 5,676 
      benefit from inventory reserve
    		1,757   
      depreciation of property, plant and equipment
    		2,796 2,726 2,675 
      loss on disposal of property, plant and equipment
    		2 3 82 
      amortization of intangible assets
    		885 482 499 
      depreciation of right-of-use assets
    		2,041 2,143 1,997 
      fair value loss of warrant liability
    		   
      fair value gains on financial assets measured at fair value through profit or loss
    		-449   
      increase in contract liabilities
    		11,645   
      decrease in contract liabilities
    		-23,826   
      foreign currency exchange (gain)/loss
    		-49,056   
      equity-settled share-based compensation expense
    		18,703 12,589 12,377 
      deferred government grant
    		-157 -144 -124 
      decrease in trade receivables
    		96,734   
      decrease/(increase) in prepayments, other receivables and other assets
    		-16,266   
      decrease in other non-current assets
    		77   
      increase in collaboration inventories
    		-4,470  -2,818 
      increase/(decrease) in trade payables
    		19,298   
      increase/(decrease) in other payables and accruals
    		10,878   
      decrease in other non-current liabilities
    		-25  -1,229 
      increase in pledged deposits
    		   
      cash from operations
    		2,384 -109,950 -76,719 
      interest income received
    		13,479 14,372 16,281 
      income tax paid
    		71   
      interest on lease payments
    		-416 -375 -410 
      net cash provided by/(used in) operating activities
    		15,518   
      note
    		2,024 0 0 
      cash flows (used in)/ provided by investing activities
    		   
      purchase of property, plant and equipment
    		-6,243 -4,345 -5,377 
      purchase of intangible assets
    		 -2,504 -96 
      prepayment to collaborator for collaboration assets
    		-16,541 -18,566 -27,200 
      purchase of financial assets measured at fair value through profit or loss
    		-150,308   
      cash receipts of investment income
    		663 2,408 2,365 
      proceeds from disposal of property, plant and equipment
    		-2   
      addition in time deposits
    		-721,990 -1,914,455 -2,516,671 
      decrease in time deposits
    		498,273 2,159,986 2,336,985 
      net cash provided by/(used in) investing activities
    		-396,148   
      cash flows from financing activities
    		   
      proceeds from exercise of share options
    		1,589 621 2,682 
      principal portion of lease payments
    		-758 304 -1,721 
      net cash provided by/(used in) financing activities
    		831   
      net increase in cash and cash equivalents
    		-379,799   
      effect of foreign exchange rate changes
    		-343  -784 
      cash and cash equivalents at beginning of year
    		1,277,713  0 
      cash and cash equivalents at end of period
    		897,571  -269,743 
      analysis of balances of cash and cash equivalents
    		   
      cash and bank balances
    		1,156,674  -91,813 
      less: pledged deposits
    		359  -890 
      time deposits
    		258,744  178,820 
      cash and cash equivalents as stated in the statement of financial position
    		897,571  -269,743 
      cash and cash equivalents as stated in the statement of cash flows
    		897,571  -269,743 
      cash flows from operating activities
    		   
      benefit from inventory reserve*
    		   
      fair value loss/(gain) of warrant liability
    		   
      fair value gains on financial assets measured at fair value change through profit or loss
    		   
      foreign currency exchange loss/(gain)
    		   
      (increase)/decrease in trade receivables
    		   
      (increase)/decrease in prepayments, other receivables and other assets
    		   
      decrease/(increase) in other non-current assets
    		   
      (increase)/decrease in collaboration inventories*
    		   
      government grant received
    		   
      (decrease)/increase in trade payables
    		 3,018 -4,371 
      (decrease)/increase in other payables and accruals
    		 -10,025 -8,521 
      increase/(decrease) in other non-current liabilities
    		   
      increase/
    		   
      income tax received
    		   
      net cash from operating activities
    		 -95,645 -60,848 
      capex
    		 -4,345 -5,377 
      free cash flows
    		 -99,990 -66,225 
      cash flows from investing activities
    		   
      cash received from withdrawal of financial assets measured at fair value through profit or loss
    		   
      cash received from withdrawal of financial assets measured at amortized cost
    		   
      decrease in pledged deposits
    		   
      purchase of financial assets measured at amortized cost
    		   
      proceeds from issuance of ordinary shares for institutional investors, net of issuance cost
    		   
      proceeds from issuance of ordinary shares for follow on public offering, net of issuance costs
    		 0  
      proceeds from exercise of warrant by warrant holder, net of issuance cost
    		 0 0 
      proceeds from issuance of ordinary shares and warrant relating to private placement for an institutional investor
    		   
      net cash from financing activities
    		 925 961 
      cash flows used in operating activities
    		   
      fair value gain/(loss) of warrant liability
    		   
      foreign currency exchange loss
    		  -17,156 
      increase in prepayments, other receivables and other assets
    		  101 
      cash flows used in investing activities
    		   
      decrease/(addition) of pledged short-term deposits
    		   
      net cash from investing activities
    		  -209,072 
      proceeds from registered direct offering, net of issuance costs
    		   
      proceeds from issuance of ordinary shares for institutional investors, net of issuance costs
    		  0 
      fair value (gains)/losses on financial assets measured at fair value through profit or loss
    		   
      net increase/(decrease) in cash and cash equivalents
    		   
      fair value (gain)/ loss of warrant liability
    		   
      fair value loss of convertible redeemable preferred shares
    		   
      decrease/(increase) in trade receivables
    		   
      (increase)/decrease in collaboration inventories
    		   
      increase in other payables and accruals
    		   
      repayment of cash advances from related parties
    		   
      proceeds from convertible redeemable preferred shares
    		   
      proceeds from issuance of ordinary shares for initial public offering, net of issuance costs
    		   
      proceeds from issuance of ordinary shares relating to private placement by genscript
    		   
      payments of expenses for issuance of convertible redeemable preferred shares
    		   
      (reversal of)/benefit from the impairment of trade receivables
    		   
      increase in other non-current assets
    		   
      decrease/(increase) in inventories
    		   
      increase/(decrease) in trade and notes payables
    		   
      (decrease)/increase in other non-current liabilities
    		   
      (decrease)/increase in contract liabilities
    		   
      finance income received
    		   
      interest on loan from related party
    		   
      net cash flow used in operating activities
    		   
      cash advances to related parties
    		   
      collection of cash advances to related parties
    		   
      addition in pledged deposits
    		   
      net cash flows used in investing activities
    		   
      proceeds from cash advances from related parties
    		   
      proceeds from loans from related parties
    		   
      repayments of loans from related parties
    		   
      net cash flows from financing activities
    		   
      reversal of the impairment of trade receivables
    		   
      write-down of inventories to net realizable value
    		   
      income from disposal of property, plant and equipment
    		   
      amortisation of intangible assets
    		   
      fair value loss of warrant lability
    		   
      fair value gains on financial assets at fair value change through profit or loss
    		   
      equity-settled share-based compensation expenses
    		   
      (increase)/decrease in inventories
    		   
      (decrease)/increase in trade and notes payables
    		   
      decrease of pledged short-term deposits
    		   
      net cash flows used in operating activities
    		   
      proceeds from disposal of items of property, plant and equipment
    		   
      purchase of financial assets at fair value through profit or loss
    		   
      cash received from withdrawal of financial assets at fair value through profit or loss
    		   
      cash receipts from investment income
    		   
      purchase of financial investment measured at amortized cost
    		   
      addition of time deposits
    		   
      proceeds from issuance of ordinary shares relating to private placement for an institutional investor
    		   
      payments of expenses for issuance convertible redeemable preferred shares
    		   
      proceeds from exercise of share option
    		   
      cash and cash equivalents at beginning of period
    		   
      less: pledged short-term deposits
    		   
      benefit from/ (reversal of) for the impairment of trade receivables
    		   
      foreign currency exchange gain
    		   
      increase in inventories
    		   
      increase in other non-current liabilities
    		   
      increase of pledged short-term deposits
    		   
      cash (used in) /from operations
    		   
      net cash flow (used in)/from operating activities
    		   
      net cash flows (used in)/from operating activities
    		   
      addition of short-term time deposits
    		   
      decrease in short-term deposits
    		   
      addition of pledged short-term deposits
    		   
      decrease in pledged short-term deposits
    		   
      cash and cash equivalents at end of year
    		   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.